相关实验视频

Updated: May 15, 2025

A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy

A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy

Published on: February 21, 2025

仿真抗原受体工程细胞疗法的多种潜力:超越癌症

Lvying Wu¹, Lingfeng Zhu², Jin Chen^1,2

¹Institute of Clinical Medicine, The Second Affiliated Hospital of Hainan Medical University, Haikou, Hainan, China.

Clinical and translational medicine

|April 10, 2025

概括

化学抗原受体 (CAR) 工程细胞疗法表明,除了治疗癌症外,还有望治疗自身免疫性疾病和感染. 需要进一步的研究,以克服CAR细胞疗法的更广泛临床应用所面临的挑战.

科学领域:

细胞疗法是一种细胞疗法.
免疫治疗是一种免疫疗法.
再生医学是一种再生医学.

背景情况:

化学抗原受体 (CAR) 工程细胞疗法已经彻底改变了血液癌症治疗.
这一成功刺激了对非癌症疾病的CAR疗法的研究,取得了显著的进展.

研究的目的:

审查关于非癌症疾病的CAR工程细胞疗法的最新研究.
突出CAR-T细胞治疗在传染病,自身免疫,心脏和移植相关疾病中的应用.
讨论目前阻碍更广泛临床采用的挑战.

主要方法:

关于CAR细胞治疗研究的综合文献综述.
专注于不同非癌症疾病模型中的CAR-T细胞治疗应用.
对临床翻译的障碍和未来方向的分析.

主要成果:

针对自身免疫性疾病,感染,心脏病和移植拒绝等,正在探索CAR细胞疗法.
目前正在研究各种CAR平台,包括CAR-T,CAR-NK和CAR-M细胞.
在将CAR技术应用于非癌症疾病方面取得了重大进展.

结论:

基于CAR的细胞疗法具有治疗广泛的非癌症疾病的潜力.
克服安全性,有效性和实用性的挑战对于临床翻译至关重要.
持续的研究和技术优化对于实现CAR细胞治疗的全部治疗潜力至关重要.

关键词:

自身免疫性疾病自身免疫性疾病心脏病:心脏病是一种心脏病.仿制性抗原受体的仿制性抗原受体传染病是一种传染性疾病.移植移植移植移植

更多相关视频

In Vitro Tumor Cell Rechallenge For Predictive Evaluation of Chimeric Antigen Receptor T Cell Antitumor Function

In Vitro Tumor Cell Rechallenge For Predictive Evaluation of Chimeric Antigen Receptor T Cell Antitumor Function

Published on: February 27, 2019

Non-Viral Engineering of Primary Human T Cells via Homology-Mediated End-Joining Targeted Integration of Large DNA Templates

Non-Viral Engineering of Primary Human T Cells via Homology-Mediated End-Joining Targeted Integration of Large DNA Templates

Published on: May 9, 2025

相关概念视频

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...